These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 30433836

  • 1. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
    Shi DY, Chen BY, Mao YY, Zhou G, Lu JS, Yu YZ, Zhou XW, Sun ZW.
    Hum Vaccin Immunother; 2019; 15(3):755-760. PubMed ID: 30433836
    [Abstract] [Full Text] [Related]

  • 2. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y, Shi D, Liu S, Gong ZW, Wang S, Sun Z.
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB.
    Hum Vaccin Immunother; 2020; 16(1):100-108. PubMed ID: 31210561
    [Abstract] [Full Text] [Related]

  • 4. Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.
    Liu FJ, Shi DY, Mao YY, Xiong XH, Lu JS, Pang XB, Dong XJ, Yang ZX, Yu YZ.
    Vaccine; 2020 Mar 23; 38(14):2978-2983. PubMed ID: 32113807
    [Abstract] [Full Text] [Related]

  • 5. Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
    White DM, Pellett S, Jensen MA, Tepp WH, Johnson EA, Arnason BG.
    Infect Immun; 2011 Aug 23; 79(8):3388-96. PubMed ID: 21576339
    [Abstract] [Full Text] [Related]

  • 6. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
    Gao YL, Gao S, Kang L, Nie C, Wang JL.
    Hum Vaccin; 2010 Jun 23; 6(6):462-6. PubMed ID: 20519939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C, da Cunha CE, Moreira GM, Mendonça M, Salvarani FM, Moreira ÂN, Conceição FR.
    Anaerobe; 2016 Aug 23; 40():58-62. PubMed ID: 27236078
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Subunit vaccine efficacy against Botulinum neurotoxin subtypes.
    Henkel JS, Tepp WH, Przedpelski A, Fritz RB, Johnson EA, Barbieri JT.
    Vaccine; 2011 Oct 13; 29(44):7688-95. PubMed ID: 21839134
    [Abstract] [Full Text] [Related]

  • 13. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B, Colliou N, Zadeh M, Ge Y, Gong M, Owen JL, Valletti M, Jobin C, Mohamadzadeh M.
    Vaccine; 2018 Jan 02; 36(1):155-164. PubMed ID: 29180028
    [Abstract] [Full Text] [Related]

  • 14. Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models.
    You Z, Yang H, Xin W, Kang L, Gao S, Wang J, Zhang T, Wang J.
    Hum Vaccin Immunother; 2014 Jan 02; 10(8):2321-7. PubMed ID: 25424938
    [Abstract] [Full Text] [Related]

  • 15. Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast.
    Liu B, Shi D, Chang S, Gong X, Yu Y, Sun Z, Wu J.
    Sci Rep; 2015 Jan 08; 5():7678. PubMed ID: 25567004
    [Abstract] [Full Text] [Related]

  • 16. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y, Yu J, Li N, Wang S, Yu W, Sun Z.
    Vaccine; 2009 Oct 19; 27(44):6148-53. PubMed ID: 19712769
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge.
    Kim NY, Ahn HB, Yu CH, Song DH, Hur GH, Shin YK, Shin S.
    Hum Vaccin Immunother; 2019 Oct 19; 15(2):412-419. PubMed ID: 30235058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.